IL6 and breast carcinoma: Mechanistically, IL-6 is implicated in both MDSC recruitment and Th17/ Th22 polarization [33,38], yet no studies have explored whether chronic overexpression of IL-6 from a developing tumor may, in fact, elicit both MDSC and type 3 Th expansion in the context of mammary carcinoma.